Utility of (1-3)-b-d-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections

Clinical Infectious Diseases

Volumn 58, Issue 5, 2014, Pages 622-630

  Litvintseva, Anastasia P ^a   Lindsley, Mark D ^a   Gade, Lalitha ^a   Smith, Rachel ^a   Chiller, Tom ^a   Lyons, Jennifer L ^b   Thakur, Kiran T ^c   Zhang, Sean X ^d   Grgurich, Dale E ^e   Kerkering, Thomas M ^e   Brandt, Mary E ^a   Park, Benjamin J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Neurology Mayo Clinic SW   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

Author keywords

(1 3) b d glucan; Exserohilum; fungal meningitis; Fungitell

Indexed keywords

BETA GLUCAN; BETA-1,3-D-GLUCAN;

ADOLESCENT; ADULT; AGED; CEREBROSPINAL FLUID; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DRUG MONITORING; EPIDEMIC; EVALUATION STUDY; FEMALE; HUMAN; MALE; MENINGITIS, FUNGAL; MIDDLE AGED; PROCEDURES; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-GLUCANS; CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC TESTS, ROUTINE; DISEASE OUTBREAKS; DRUG MONITORING; FEMALE; HUMANS; MALE; MENINGITIS, FUNGAL; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 84894247375     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit808     Document Type: Article

References (22)

1. Smith RM, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013; 369:1598-609.
2. Centers for Disease Control and Prevention. Multistate outbreak of fungal infection associated with injection of methylprednisolone acetate solution from a single compounding pharmacy-United States, 2012. MMWR Morb Mortal Wkly Rep 2012; 61:839-42.
3. Lockhart SR, Pham CD, Gade L, et al. Fungal infections associated with contaminated methylprednisolone injections-preliminary laboratory report. J Clin Microbiol 2013; 51:2654-61.
4. Bell WR, Dalton JB, McCall CM, et al. Iatrogenic Exserohilum infection of the central nervous system: mycological identification and histopathological findings. Mod Pathol 2013; 26:166-70.
5. Ohm RA, Feau N, Henrissat B, et al. Diverse lifestyles and strategies of plant pathogenesis encoded in the genomes of eighteen Dothideomycetes fungi. PLoS Pathog 2012; 8:e1003037.
6. Adler A, Yaniv I, Samra Z, et al. Exserohilum: an emerging human pathogen. Eur J Clin Microbiol Infect Dis 2006; 25:247-53.
7. Douer D, Goldschmied-Reouven A, Segev S, Ben-Bassat I. Human Exserohilum and Bipolaris infections: report of Exserohilum nasal infection in a neutropenic patient with acute leukemia and review of the literature. J Med Vet Mycol 1987; 25:235-41.
8. Gade L, Scheel CM, Pham CD, et al. Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell 2013; 12: 677-83.
9. Tsoni SV, Brown GD. Beta-glucans and dectin-1. Ann NY Acad Sci 2008; 1143:45-60.
10. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199-205.
11. Ahmad S, Khan ZU, Theyyathel AM. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus. Diag Microbiol Infect Dis 2007; 59:165-71.
12. Alexander BD, Smith PB, Davis RD, Perfect JR, Reller LB. The (1,3) {beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation. J Clin Microbiol 2010; 48: 4083-8.
13. Petraitiene R, Petraitis V, Hope WW, et al. Cerebrospinal fluid and plasma (1-3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrob Agents Chemother 2008; 52:4121-9.
14. Mikulska M, Furfaro E, Del Bono V, et al. (1-3)-beta-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. Clin Infect Dis 2013; 56:1511-2.
15. Lyons JL, Roos KL, Marr KA, et al. Cerebrospinal fluid (1,3)-beta-Dglucan detection as an aid for diagnosis of iatrogenic fungal meningitis. J Clin Microbiol 2013; 51:1285-7.
16. Kerkering TM, Grifasi ML, Baffoe-Bonnie AW, et al. Early clinical observations in prospectively followed patients with fungal meningitis related to contaminated epidural steroid injections. Ann Intern Med 2013; 158:154-61.
17. Smith RM, Tipple M, Chaudry MN, Schaefer MK, Park BJ. Relapse of fungal meningitis associated with contaminated methylprednisolone. N Engl J Med 2013; 368:2535-6.
18. Centers for Disease Control and Prevention. Interim treatment guidance for central nervous system and parameningeal infections associated with injection of contaminated steroid products. 2013. Available at: http://www.cdc.gov/hai/outbreaks/clinicians/guidance-cns.html. Accessed 17 July 2013.
19. Brown GD, Gordon S. Immune recognition of fungal beta-glucans. Cell Microbiol 2005; 7:471-9.
20. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001; 291:1304-51.
21. Albert O, Toubas D, Strady C, et al. Reactivity of (1-3)-beta-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2011; 30:1453-60.
22. Peman J, Zaragoza R. Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections. Exp Rev Anti Infect Ther 2012; 10:1321-30.